Overview

Bimatoprost for the Treatment of Eyebrow Hypotrichosis

Status:
Completed
Trial end date:
2014-02-11
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

-Adult participants with eyebrow hypotrichosis (inadequate eyebrow growth).

Exclusion Criteria:

- Patients with disease, infection, or abnormality of the eyebrow area

- Patients with permanent eyebrow loss due to over-grooming